RecruitingPhase 3NCT06643130

Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia

A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia

Sponsor

JW Pharmaceutical

Enrollment

162 participants

Start Date

Dec 2, 2024

Study Type

INTERVENTIONAL

Conditions

Hypertension Dyslipidemia

Summary

A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients with Hypertension and Dyslipidemia

Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This trial is evaluating the safety and effectiveness of taking two medications together — JW0104 (for blood pressure) and C2402 (for high cholesterol) — in people who have both high blood pressure and high cholesterol. **You may be eligible if...** - You have both high blood pressure (hypertension) and high cholesterol (dyslipidemia) **You may NOT be eligible if...** - Your blood pressure and LDL cholesterol levels do not fall within the ranges specified for this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.